By understanding the genetic basis of neonatal disorders, researchers can develop [targeted therapies]() that address the specific genetic mutations involved. For instance, gene therapy can potentially correct defective genes, while [pharmacogenomics]() can help tailor medications based on the genetic profile of the newborn. These advancements can lead to more effective and personalized treatments.
